Possible roles of an adult T-cell leukemia (ATL)-derived factor/thioredoxin in the drug resistance of ATL to adriamycin

Blood

Volumn 89, Issue 7, 1997, Pages 2480-2487

  Wang, Jingxin ^a   Kobayashi, Masanobu ^a   Sakurada, Keisuke ^a   Imamura, Masahiro ^a   Moriuchi, Tetsuya ^a   Hosokawa, Masuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; GLUTATHIONE PEROXIDASE; GLYCOPROTEIN P; THIOREDOXIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; T CELL LEUKEMIA;

EID: 0030956591     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2480     Document Type: Article

References (30)

1. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T, Takigawa M, Sasaki M, Minato N, Tsudo M, Uchiyama T, Maeda M: TCGF (IL-2)-receptor inducing factor (s). I. Regulation of IL-2 receptor on a natural killer cell line (YT cells). J Immunol 134:1623, 1985
2. + T cell lines. J Immunol 135:3995, 1985
3. + T cell lines. Immunol Lett 15:221, 1987
4. Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, Tursz T: Adult T cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type 1 and Epstein Barr virus-transformed lymphocytes, acts as an autocrine factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci USA 87:8282, 1990
5. Yodoi J, Tursz T: ADF: An endogenous reducing protein homologous to thioredoxin; involvement in lymphocyte immortalization by HTLV-1 and EBV. Adv Cancer Res 57:381, 1991
6. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, Yodoi J: ATL-derived factor (ADF), an IL-2R/Tac inducer homologous to thioredoxin: Possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8:757, 1989
7. Wollman EE, Aurio L, Rimsky L, Shaw A, Jacquot JP, Wingfield P, Graber P, Dessarps F, Robin P, Galibert F, Bertoglio J, Fradelizi D: Cloning and expression of a cDNA for human thioredoxin. J Biol Chem 263:15508, 1988
8. Holmgren A: Thioredoxin. Annu Rev Biochem 54:237, 1985
9. Scalreuter KU, Wood JM: The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Commun 136:630, 1986
10. 2 upon thioredoxin-enriched lens epithelial cells. J Biol Chem 263:4984, 1988
11. Matsuda M, Matsutani H, Nakamura H, Miyajima S, Yamaguchi A, Yonehara S, Uchida A, Irimajiri K, Horiuchi A, Yodoi J: Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U 937 cells. J Immunol 147:3837, 1991
12. Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M, Kohno K: Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 55:4293, 1995
13. Suemizu H, Yoshimura S, Tada N, Watanabe K, Moriuchi T: Production and characterization of two monoclonal antibodies to human glutathione peroxidase. Hybridoma 11:795, 1992
14. Kobayashi M, Nagayasu H, Hamada J-I, Takeichi N, Hosokawa M: ONO-4007, a new synthetic lipid A derivative, induces differentiation of rat myelomonocytic leukemia cells in vitro and in vivo. Exp Hematol 22:454, 1994
15. Kumar S, Bjornstedt M, Holmgren A: Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur J Biochem 207:435, 1992
16. Bjornstedt M, Kumar S, Holmgren A: Selenoglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. J Biol Chem 267:8030, 1992
17. Sato N, Iwata S, Nakamura K, Hori T, Mori K, Yodoi J: Thiol-mediated redox regulation of apoptosis; possible roles of cellular thiols other than glutathion in T cell apoptosis. J Immunol 154:3194, 1995
18. Horning SJ, Weiss LM, Grabtree GS, Warnke RA: Clinical and phenotypic diversity of T cell lymphoma. Blood 67:1578, 1986
19. Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatuki K, Ichimaru M, Tomonaga S, Tsugane S, Minato K, Tobinai K, Oyama A, Hisano S, Matsumoto M, Takiguchi T, Yamaguchi K, Kinoshita K, Tajima K, Suematsu K, for the Lymphoma Study Group (1981-1983): Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J Clin Oncol 6:1088, 1988
20. Shimoyama M, and the Lymphoma Study Group (1984-1987): Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br J Haematol 78:428, 1991
21. Kuwazuru Y, Harada S, Furukawa T, Yoshimura A, Sumizawa T, Utsunomiya A, Ishibashi K, Saito T, Uozumi K, Maruyama M, Ishizawa M, Arima T, Akiyama S: Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 76:2065, 1990
22. Rothenberg ML, Mickley LA, Cole DE, Balis FM, Tsuruo T, Poplack DG, Fojo AT: Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood 74:1388, 1989
23. Goasguen JE, Dossot J-M, Fardel O, Mee FL, Gall EL, Lebley R, LePrise PY, Chaperon J, Fauchet R: Expression of multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: Prognostic implications. Blood 81:2394, 1993
24. Benchekroun N, Pourquier P, Schott B, Robert J: Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicin. Eur J Biochem 207:141, 1992
25. Ip C, Ip MM: Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A. Carcinogenesis 2:915, 1981
26. Mitsui A, Hirakawa T, Yodoi J: Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem Biophys Res Commun 186: 1220, 1992
27. Handel ML, Wars CK, deFazio A, Day RO, Sutherland RL: Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. Proc Natl Acad Sci USA 92:4479, 1995
28. Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN, Hou C: A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 29:289, 1991
29. Jiang XR, Macey MG, Newland AC: The anti-leukemic effects and the mechanisms of sodium selenite. Leuk Res 16:347, 1992
30. Medina D, Osborn CJ: Selenium inhibition of DNA synthesis in mouse mammary epithelial cell line YN-4. Cancer Res 44:4361, 1984